Cited by 279

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Neu and its ligands: From an oncogene to neural factors

Peles, Elior, Yarden, Yosef·1993·BioEssays

Open this paper in CoChat — free account

Abstract

Transmembrane receptor tyrosine kinases that bind to peptide factors transmit essential growth and differentiation signals. A growing list of orphan receptors, of which some are oncogenic, holds the promise that many unknown ligands may be discovered by tracking the corresponding surface molecules. The neu gene (also called erb B‐2 and HER‐2) encodes such a receptor tyrosine kinase whose oncogenic potential is released in the developing rodent nervous system through a point mutation. Amplification and overexpression of neu are thought to contribute to malignancy of certain human adenocarcinomas. The search for soluble factors that interact with the Neu receptor led to the discovery of a 44 kDa glyco‐protein that induces phenotypic differentiation of cultured mammary tumor cells to growth‐arrested and milk‐producing cells. The Neu differentiation factor (NDF or heregulin), however, also acts as a mitogen for epithelial, Schwann and glial cells. Multiple forms of the factor are produced by alternative splicing and their expression is confined predominantly to the central and to the peripheral nervous systems. One identified neuronal function of this family of polypeptides is to control the formation of neuromuscular junctions, but their physiological role in secretory epithelia is still unknown. Other open questions relate to the transmembrane topology of various precursors, the identity of a putative co‐receptor, the possible existence of additional ligands of Neu and the functional significance of the interaction between Neu and at least three highly related receptor tyrosine kinases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/bies.950151207

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., & Leder, P. (1988) · Cell · doi:10.1016/0092-8674(88)90184-5 · Cited by 1,165
erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 Cells
Di Fiore, P. P., Pierce, J. H., Kraus, M. H., Segatto, O., King, C. R., & Aaronson, S. A. (1987) · Science · doi:10.1126/science.2885917 · Cited by 1,010
Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185
Bargmann, C. I., Hung, M.-C., & Weinberg, R. A. (1986) · Cell · doi:10.1016/0092-8674(86)90779-8 · Cited by 1,006
Identification of Heregulin, a Specific Activator of p185 erbB2
Holmes, W. E., Sliwkowski, M. X., Akita, R. W., Henzel, W. J., Lee, J., Park, J. W., Yansura, D., Abadi, N., Raab, H., Lewis, G. D., et al. (1992) · Science · doi:10.1126/science.256.5060.1205 · Cited by 962
Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system
Marchionni, M. A., Goodearl, A. D. J., Su Chen, M., Bermingham-McDonogh, O., Kirk, C., Hendricks, M., Danehy, F., Misumi, D., Sudhalter, J., Kobayashi, K., et al. (1993) · Nature · doi:10.1038/362312a0 · Cited by 738
Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.
Plowman, G. D., Culouscou, J. M., Whitney, G. S., Green, J. M., Carlton, G. W., Foy, L., Neubauer, M. G., & Shoyab, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1746 · Cited by 713
Clonal cell lines from the rat central nervous system
Schubert, D., Heinemann, S., Carlisle, W., Tarikas, H., Kimes, B., Patrick, J., Steinbach, J. H., Culp, W., & Brandt, B. L. (1974) · Nature · doi:10.1038/249224a0 · Cited by 712
Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.
Hudziak, R. M., Schlessinger, J., & Ullrich, A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7159 · Cited by 625
ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family
Falls, D. (1993) · Cell · doi:10.1016/0092-8674(93)90407-h · Cited by 607
Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit
Wen, D., Peles, E., Cupples, R., Suggs, S. V., Bacus, S. S., Luo, Y., Trail, G., Hu, S., Silbiger, S. M., Levy, R. B., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90456-m · Cited by 577
Self-citation
Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
Berger, M. S., Locher, G. W., Saurer, S., Gullick, W. J., Waterfield, M. D., Groner, B., & Hynes, N. E. (1988) · PubMed · Cited by 565
Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the SId mutant
Flanagan, J. G., Chan, D. C., & Leder, P. (1991) · Cell · doi:10.1016/0092-8674(91)90326-t · Cited by 550
Isolation of the NeuHER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells
Peles, E., Bacus, S. S., Koski, R. A., Lu, H. S., Wen, D., Ogden, S. G., Levy, R. B., & Yarden, Y. (1992) · Cell · doi:10.1016/0092-8674(92)90131-u · Cited by 524
Self-citation
p185neu expression in human lung adenocarcinomas predicts shortened survival.
Kern, J. A., Schwartz, D. A., Nordberg, J. E., Weiner, D. B., Greene, M. I., Torney, L., & Robinson, R. A. (1990) · PubMed · Cited by 434
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation
Weiner, D. B., Liu, J., Cohen, J. A., Williams, W. V., & Greene, M. I. (1989) · Nature · doi:10.1038/339230a0 · Cited by 423
Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies
Drebin, J. A., Link, V. C., Stern, D. F., Weinberg, R. A., & Greene, M. I. (1985) · Cell · doi:10.1016/s0092-8674(85)80050-7 · Cited by 400
Intermolecular association of the p185 protein and EGF receptor modulates EGF receptor function
Wada, T., Qian, X., & Greene, M. I. (1990) · Cell · doi:10.1016/0092-8674(90)90697-d · Cited by 361
Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion.
Bargmann, C. I., & Weinberg, R. A. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03044.x · Cited by 315
Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts
Kokai, Y., Myers, J. N., Wada, T., Brown, V. I., LeVea, C. M., Davis, J. G., Dobashi, K., & Greene, M. I. (1989) · Cell · doi:10.1016/0092-8674(89)90843-x · Cited by 309
Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic
Shepard, H. M., Lewis, G. D., Sarup, J. C., Fendly, B. M., Maneval, D., Mordenti, J., Figari, I., Kotts, C. E., Palladino, M. A., Ullrich, A., et al. (1991) · Journal of Clinical Immunology · doi:10.1007/bf00918679 · Cited by 294
Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185 erb B2
Lupu, R., Colomer, R., Zugmaier, G., Sarup, J., Shepard, M., Slamon, D., & Lippman, M. E. (1990) · Science · doi:10.1126/science.2218496 · Cited by 277
Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation
Goldman, R., Ben Levy, R., Peles, E., & Yarden, Y. (1990) · Biochemistry · doi:10.1021/bi00502a002 · Cited by 244
Self-citation
Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships.
Peles, E., Ben-Levy, R., Tzahar, E., Liu, N., Wen, D., & Yarden, Y. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05737.x · Cited by 233
Self-citation
Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.
Bargmann, C. I., & Weinberg, R. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5394 · Cited by 224
Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth.
Stancovski, I., Hurwitz, E., Leitner, O., Ullrich, A., Yarden, Y., & Sela, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8691 · Cited by 203
Self-citation
Neu receptor dimerization
Sternberg, M. J. E., & Gullick, W. J. (1989) · Nature · doi:10.1038/339587a0 · Cited by 151
HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor.
Lee, J., Dull, T. J., Lax, I., Schlessinger, J., & Ullrich, A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03361.x · Cited by 131
4. The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer
Gullick, W. J. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460708 · Cited by 128
The cytoplasmic carboxy-terminal amino acid specifies cleavage of membrane TGFα into soluble growth factor
Bosenberg, M., Pandiella, A., & Massagué, J. (1992) · Cell · doi:10.1016/s0092-8674(05)80064-9 · Cited by 127
Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma.
Peles, E., Levy, R. B., Or, E., Ullrich, A., & Yarden, Y. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07739.x · Cited by 118
Self-citation
The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.
Lonardo, F., Marco, E. D., King, C. R., Pierce, J. H., Segatto, O., Aaronson, S. A., & Fiore, P. P. D. (1990) · PubMed · Cited by 115
Expression of theneuproto‐oncogene by schwann cells during peripheral nerve development and wallerian degeneration
Cohen, J. A., Yachnis, A. T., Arai, M., Davis, J. G., & Scherer, S. S. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310406 · Cited by 111
Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-erbB-2 receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation.
Taverna, D., Groner, B., & Hynes, N. E. (1991) · PubMed · Cited by 110
Experimental approaches to hypothetical hormones: detection of a candidate ligand of the neu protooncogene.
Yarden, Y., & Weinberg, R. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3179 · Cited by 105
Self-citation
Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses.
Spivak-Kroizman, T. R., Rotin, D., Pinchasi, D., Ullrich, A., Schlessinger, J., & Lax, I. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42407-6 · Cited by 104
Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active.
Yarden, Y. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2569 · Cited by 103
Self-citation
Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.
Bacus, S. S., Stancovski, I., Huberman, E., Chin, D., Hurwitz, E., Mills, G. B., Ullrich, A., Sela, M., & Yarden, Y. (1992) · PubMed · Cited by 101
Self-citation
Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation.
Peles, E., Lamprecht, R., Ben-Levy, R., et al. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49834-7 · Cited by 90
Self-citation
Induction of a variety of tumors by c‐erbB2 and clonal nature of lymphomas even with the mutated gene (Val659‐‐‐‐Glu659).
Suda, Y., Aizawa, S., Furuta, Y., Yagi, T., Ikawa, Y., Saitoh, K., Yamada, Y., Toyoshima, K., & Yamamoto, T. S. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08094.x · Cited by 89
p185HER2 signal transduction in breast cancer cells
Scott, G. K., Dodson, J. M., Montgomery, P. A., Johnson, R. M., Sarup, J. C., Wong, W., Ullrich, A., Shepard, H. M., & Benz, C. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98683-7 · Cited by 87
The erb B-2 Mitogenic Signaling Pathway: Tyrosine Phosphorylation of Phospholipase C-γ and GTPase-Activating Protein Does Not Correlate with erb B-2 Mitogenic Potency
Fazioli, F., Kim, U. H., Rhee, S. G., Molloy, C. J., Segatto, O., & Fiore, P. P. D. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.2040 · Cited by 85
A chimeric EGF‐R‐neu proto‐oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
Lehväslaiho, H., Lehtola, L., Sistonen, L., & Alitalo, K. K. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03360.x · Cited by 80
Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase.
Sistonen, L., Hölttä, E., Lehväslaiho, H., Lehtola, L., & Alitalo, K. K. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.109.5.1911 · Cited by 80
Tyrosine phosphatase inhibition permits analysis of signal transduction complexes in p185HER2/neu-overexpressing human tumor cells.
Jallal, B., Schlessinger, J., & Ullrich, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42843-8 · Cited by 58
An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.
Ben-Levy, R., Peles, E., Goldman-Michael, R., & Yarden, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41926-6 · Cited by 50
Self-citation
The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.
Connelly, P. A., & Stern, D. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6054 · Cited by 50
Signal transduction by the neu/ebrB-2 receptor: A potential target for anti-tumor therapy
Stancovski, I., Peles, E., Levy, R. B., Lemprecht, R., Kelman, Z., Goldman-Michael, R., Hurwitz, E., Bacus, S. S., Sela, M., & Yarden, Y. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90192-l · Cited by 24
Self-citation

Epidermal growth factor-related peptides and their receptors in human malignancies
Salomon, D. S., Brandt, R., Ciardiello, F., & Normanno, N. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00144-i · Cited by 2,690
Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.
Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B. J., Sela, M., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00603.x · Cited by 769
Self-citation
Embryo Implantation
Carson, D. D., Bagchi, I., Dey, S. K., Enders, A. C., Fazleabas, A. T., Lessey, B. A., & Yoshinaga, K. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9767 · Cited by 676
ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
Karunagaran, D., Tzahar, E., Beerli, R. R., Chen, X., Graus-Porta, D., Ratzkin, B. J., Seger, R., Hynes, N. E., & Yarden, Y. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00356.x · Cited by 674
Self-citation
The ErbB receptors and their role in cancer progression
Holbro, T. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00099-x · Cited by 608

See all 279

Authors: Peles, E., & Yarden, Y.
Venue: BioEssays
Publisher: Wiley
Published: 1993-12
Volume: 15
Issue: 12
Pages: 815-824
ISSN: 0265-9247 (ISSN-L)
1521-1878
DOI: 10.1002/bies.950151207
OpenAlex: W1987657791
Cited by: 279
References: 49
FWCI: 2.21
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Neu and its ligands: From an oncogene to neural factors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources